Evidence map›Paper›PMID 40555747›Full record

ArticleCommunications biology2025

Bifidobacterium deficit in United States infants drives prevalent gut dysbiosis.

John B Jarman, Pedro J Torres, Sean Stromberg, Hirokazu Sato, Caroline Stack, Angelica Ladrillono, Shannon Pace, Natalia Livier Jimenez, Robert J Haselbeck, Richard Insel and 2 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
  4. Clostridium Abundance and Lower Weight-for-AgeJMIR pediatrics and parenting · 2026
    Article
  5. Follow the microbes: a new perspective on health inequalities.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. mSphere · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Metabolic interactions and growth dynamics ofFrontiers in microbiology · 2026
    Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

John B Jarman *Persephone Biosciences, San Diego, CA, USA.
Pedro J Torres *Persephone Biosciences, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-0606-8482
Sean StrombergPersephone Biosciences, San Diego, CA, USA.
Hirokazu SatoPersephone Biosciences, San Diego, CA, USA.
Caroline StackPersephone Biosciences, San Diego, CA, USA.
Angelica LadrillonoPersephone Biosciences, San Diego, CA, USA.
Shannon PacePersephone Biosciences, San Diego, CA, USA.
Natalia Livier JimenezPersephone Biosciences, San Diego, CA, USA.
Robert J HaselbeckPersephone Biosciences, San Diego, CA, USA.
Richard InselDepartment of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.ORCID http://orcid.org/0000-0003-0100-9077
Stephen Van DienPersephone Biosciences, San Diego, CA, USA.
Stephanie J CullerPersephone Biosciences, San Diego, CA, USA. sculler@persephonebiome.com.ORCID http://orcid.org/0009-0003-7996-5170

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The composition of the infant gut microbiome is critical to immune development and noncommunicable disease (NCD) trajectory. However, a comprehensive evaluation of the infant gut microbiome in the United States is lacking. The My Baby Biome study, designed to address this knowledge gap, evaluated the gut microbiomes of 412 infants (representative of U.S. demographic diversity) using metagenomics and metabolomics. Regardless of birth mode and/or feeding method, widespread Bifidobacterium deficit was observed, with approximately 25% of U.S. infants lacking detectable Bifidobacterium. Bifidobacterium-dominant microbiomes exhibit distinct features when compared to microbiomes with other dominant microbial compositions including reduced antimicrobial resistance and virulence factor genes, altered carbohydrate utilization pathways, and altered metabolic signatures. In C-section birth infants, Bifidobacterium tended to be replaced in the human milk oligosaccharide utilization niche with potentially pathogenic species. Longitudinal health outcomes from these infants suggest that the disappearance of key Bifidobacterium may contribute to the development of atopy.

Indexed as

BifidobacteriumDysbiosisGastrointestinal MicrobiomeFemaleHumansInfantInfant, NewbornMaleMetagenomicsUnited States

Identifiers

PMID40555747
PMCPMC12187928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.